Clinical Trials
2 trialsNCT04198480 2019-12-13
A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM
Shanghai JMT-Bio Inc.
Phase 1/2 Unknown
NCT00060138 2013-05-15
Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
Chugai Pharmaceutical
Phase 1/2 Completed